Endocan as a prognostic biomarker of triple-negative breast cancer.
Sagara A, Igarashi K, Otsuka M, Kodama A, Yamashita M, Sugiura R, Karasawa T, Arakawa K, Narita M, Kuzumaki N, Narita M, Kato Y.
Sagara A, et al. Among authors: otsuka m.
Breast Cancer Res Treat. 2017 Jan;161(2):269-278. doi: 10.1007/s10549-016-4057-8. Epub 2016 Nov 25.
Breast Cancer Res Treat. 2017.
PMID: 27888420
Free PMC article.